[go: up one dir, main page]

NO20030811L - Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer - Google Patents

Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer

Info

Publication number
NO20030811L
NO20030811L NO20030811A NO20030811A NO20030811L NO 20030811 L NO20030811 L NO 20030811L NO 20030811 A NO20030811 A NO 20030811A NO 20030811 A NO20030811 A NO 20030811A NO 20030811 L NO20030811 L NO 20030811L
Authority
NO
Norway
Prior art keywords
receptors
dopamine
hta1
treatment
diseases associated
Prior art date
Application number
NO20030811A
Other languages
English (en)
Other versions
NO20030811D0 (no
Inventor
Rudolf Gottschlich
Karl-August Ackermann
Helmut Pruecher
Christoph Seyfried
Gerd Bartoszyk
Christoph Van Amsterdam
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030811D0 publication Critical patent/NO20030811D0/no
Publication of NO20030811L publication Critical patent/NO20030811L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye kromenonderivater med formel I, hvor Y, X, R, R, Rog n har én av betydningene angitt i patentkrav 1, som inhibitorer for 5-HT-reseptoren og for dopamin-D-reseptoren.
NO20030811A 2000-08-24 2003-02-21 Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer NO20030811L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10041574A DE10041574A1 (de) 2000-08-24 2000-08-24 Chromenonderivate
PCT/EP2001/008528 WO2002016354A1 (de) 2000-08-24 2001-07-24 Chromenonderivate und ihre verwendung zur behandlung von krankheiten im zusammenhang mit 5-hta1-rezeptoren und/oder dopamin-d2-rezeptoren

Publications (2)

Publication Number Publication Date
NO20030811D0 NO20030811D0 (no) 2003-02-21
NO20030811L true NO20030811L (no) 2003-02-21

Family

ID=7653636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030811A NO20030811L (no) 2000-08-24 2003-02-21 Kromenonderivater og anvendelse derav til behandling av sykdommer i forbindelse med 5-HTA1-reseptorer og/eller dopamin-D2-reseptorer

Country Status (16)

Country Link
US (1) US20040014768A1 (no)
EP (1) EP1311503A1 (no)
JP (1) JP2004506733A (no)
KR (1) KR20030022390A (no)
CN (1) CN1447807A (no)
AU (1) AU2001289735A1 (no)
BR (1) BR0113364A (no)
CA (1) CA2420206A1 (no)
CZ (1) CZ2003659A3 (no)
DE (1) DE10041574A1 (no)
MX (1) MXPA03001609A (no)
NO (1) NO20030811L (no)
PL (1) PL359222A1 (no)
SK (1) SK2942003A3 (no)
WO (1) WO2002016354A1 (no)
ZA (1) ZA200302255B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007956A1 (en) 2001-07-20 2003-01-30 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
DE10217006A1 (de) * 2002-04-16 2003-11-06 Merck Patent Gmbh Substituierte Indole
US7160888B2 (en) 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
ATE450041T1 (de) 2004-03-26 2009-12-15 Lg Electronics Inc Aufzeichnungsmedium und verfahren und vorrichtung zum wiedergeben eines auf dem aufzeichnungsmedium aufgezeichneten textuntertitelstroms
RU2378722C2 (ru) 2004-03-26 2010-01-10 ЭлДжи ЭЛЕКТРОНИКС ИНК. Носитель записи, способ и устройство для воспроизведения потоков текстовых субтитров
WO2012087229A1 (en) * 2010-12-20 2012-06-28 Astrazeneca Ab 2-carboxamide-4-piperazinyl-benzofuran derivative
CN104059046B (zh) * 2013-03-18 2017-02-08 江苏恩华药业股份有限公司 黄酮类衍生物及其应用
CN116332918B (zh) * 2023-03-17 2025-07-25 遵义医科大学珠海校区 香豆素-喹啉衍生物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
DE4111861A1 (de) * 1991-04-11 1992-10-15 Schwabe Willmar Gmbh & Co Benzopyranone, verfahren zu ihrer herstellung und verwendung

Also Published As

Publication number Publication date
PL359222A1 (en) 2004-08-23
AU2001289735A1 (en) 2002-03-04
NO20030811D0 (no) 2003-02-21
CN1447807A (zh) 2003-10-08
EP1311503A1 (de) 2003-05-21
US20040014768A1 (en) 2004-01-22
BR0113364A (pt) 2003-07-15
WO2002016354A1 (de) 2002-02-28
CA2420206A1 (en) 2003-02-21
KR20030022390A (ko) 2003-03-15
DE10041574A1 (de) 2002-03-07
CZ2003659A3 (cs) 2003-06-18
SK2942003A3 (en) 2003-09-11
MXPA03001609A (es) 2003-06-04
JP2004506733A (ja) 2004-03-04
ZA200302255B (en) 2004-08-16

Similar Documents

Publication Publication Date Title
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20050649L (no) Nye tiofenylglykosidderivater, fremgangsmate for fremstilling derav, medikamenter omfattende disse forbindelser og anvendelse derav
CR8530A (es) Intermediarios de quinolona como inhibidores de receptores de tirosina quinasas y la sintesis de los mismos
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
NO20071593L (no) Pyrimidinderivater
ECSP034750A (es) Derivados de espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa-7
NO20055977L (no) Nye benzimidazolderivater
NO20022857L (no) Nye P2X7-reseptoragonister for bruk i behandling av inflammatoriske, immun- eller kardiovaskul¶re sykdommer
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
EA200501928A1 (ru) Пирролодигидроизохинолины как ингибиторы pde10
DE60318177D1 (de) Rho-kinase inhibitoren
SE0202463D0 (sv) Novel compounds
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
NO20063620L (no) Arylanilinderivater som beta2 adrenergiske receptoragonister
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
AR047529A1 (es) Compuestos de quinolina sustituidos
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
NO20054083L (no) Nye sammenkoblede triazoloner og deres anvendelse
NO20052028L (no) Pyridinderivater som CB2 reseptor modulatorer